John Livingston, MD
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John Livingston, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:27 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07193550 · A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)M.D. Anderson Cancer Center · recruiting · Bone Sarcomas · principal investigator
- Ph1NCT06083883 · Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1M.D. Anderson Cancer Center · recruiting · Synovial Sarcoma, Myxoid/Round Cell Liposarcoma · principal investigator
- Ph1NCT05621668 · A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone SarcomaM.D. Anderson Cancer Center · active not recruiting · Soft Tissue Sarcoma, Bone Sarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.